VanEck Vectors Biotech ETF Profit Margin 1970-1969 | BBH

Current and historical gross margin, operating margin and net profit margin for VanEck Vectors Biotech ETF (BBH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. VanEck Vectors Biotech ETF net profit margin as of December 31, 1969 is 0%.
VanEck Vectors Biotech ETF Annual Profit Margins
VanEck Vectors Biotech ETF Quarterly Profit Margins
Sector Industry Market Cap Revenue
Finance Finance - Publicly Traded Investment Trusts $0.349B $0.000B
The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.
Stock Name Country Market Cap PE Ratio
Sea (SE) Singapore $12.022B 0.00
Adams Diversified Equity Fund (ADX) United States $1.746B 0.00
Lifestyle Holdings (LFSYY) Hong Kong, SAR China $1.580B 0.00
Compass Diversified Holdings (CODI) United States $1.362B 16.60
Taiwan Fund (TWN) United States $0.162B 0.00
Equus Total Return (EQS) United States $0.021B 0.00
GSV Capital Corp (SSSS) United States $0.000B 0.00